DI COSTANZO, FRANCESCO
 Distribuzione geografica
Continente #
NA - Nord America 2.080
EU - Europa 1.601
AS - Asia 784
SA - Sud America 83
AF - Africa 14
OC - Oceania 6
Totale 4.568
Nazione #
US - Stati Uniti d'America 2.058
RU - Federazione Russa 605
PL - Polonia 422
SG - Singapore 251
CN - Cina 174
IT - Italia 151
HK - Hong Kong 142
IE - Irlanda 119
SE - Svezia 104
BR - Brasile 68
KR - Corea 68
FI - Finlandia 56
VN - Vietnam 40
DE - Germania 38
JO - Giordania 34
IN - India 32
GB - Regno Unito 23
FR - Francia 20
ID - Indonesia 18
CA - Canada 12
UA - Ucraina 12
AT - Austria 11
ES - Italia 11
JP - Giappone 10
BE - Belgio 7
CH - Svizzera 7
MX - Messico 7
AR - Argentina 6
AU - Australia 6
IQ - Iraq 5
NL - Olanda 5
ZA - Sudafrica 5
MA - Marocco 4
VE - Venezuela 4
IL - Israele 3
LT - Lituania 3
CI - Costa d'Avorio 2
HR - Croazia 2
UY - Uruguay 2
BD - Bangladesh 1
BY - Bielorussia 1
CL - Cile 1
CR - Costa Rica 1
DK - Danimarca 1
EC - Ecuador 1
GR - Grecia 1
HN - Honduras 1
KE - Kenya 1
LV - Lettonia 1
NI - Nicaragua 1
PH - Filippine 1
PK - Pakistan 1
PS - Palestinian Territory 1
PY - Paraguay 1
SA - Arabia Saudita 1
SI - Slovenia 1
SN - Senegal 1
TN - Tunisia 1
TR - Turchia 1
UZ - Uzbekistan 1
Totale 4.568
Città #
Santa Clara 502
Warsaw 422
Ashburn 221
Fairfield 209
Singapore 163
Hong Kong 123
Dublin 119
Chandler 116
Seattle 84
Woodbridge 77
Cambridge 68
Seoul 68
Houston 67
Wilmington 65
Beijing 53
Lawrence 43
Altamura 42
Ann Arbor 41
San Jose 41
Buffalo 37
Helsinki 35
Moscow 31
Princeton 31
Florence 25
Boston 24
Los Angeles 24
Munich 23
Mumbai 20
New York 20
Dong Ket 18
Hefei 18
Shanghai 18
Boardman 17
Dallas 16
Jakarta 16
Pisa 14
Rome 13
Medford 12
San Diego 11
The Dalles 11
Turku 11
Clifton 10
Vienna 10
Paris 9
Redondo Beach 8
Bern 7
Brussels 7
Pune 7
Redwood City 7
Tokyo 7
Barcelona 6
Norwalk 6
São Paulo 6
Toronto 6
Johannesburg 5
London 5
Melbourne 5
Bremen 4
Curitiba 4
Falls Church 4
Hillsboro 4
Ho Chi Minh City 4
Kent 4
Milan 4
Yubileyny 4
Amman 3
Atlanta 3
Charlotte 3
Frankfurt am Main 3
Guangzhou 3
Hanoi 3
Lucca 3
Mexico City 3
Mykolayiv 3
Orem 3
Shenzhen 3
Abidjan 2
Amsterdam 2
Baghdad 2
Bengaluru 2
Cantu 2
Casablanca 2
Cinisello Balsamo 2
Conversano 2
Dnipro 2
Elk Grove Village 2
Hangzhou 2
Isidro Casanova 2
Jönköping 2
Kariya 2
Lappeenranta 2
Laurel 2
Montevideo 2
Nanjing 2
Newark 2
Nuremberg 2
Ottawa 2
Owings Mills 2
Padova 2
Perugia 2
Totale 3.193
Nome #
HERG1 positivity and Glut-1 negativity identifies high-risk TNM stage I and II colorectal cancer patients, regardless of adjuvant chemotherapy 312
Adjuvant chemotherapy in completely resected gastric cancer: A randomized phase III trial conducted by GOIRC 248
Gallbladder neuroendocrine neoplasm: a case report and critical evaluation of WHO classification 245
hERG1 channels drive tumour malignancy and may serve as prognostic factor in pancreatic ductal adenocarcinoma 225
Upfront FOLFOXIRI plus bevacizumab and reintroduction after progression versus mFOLFOX6 plus bevacizumab followed by FOLFIRI plus bevacizumab in the treatment of patients with metastatic colorectal cancer (TRIBE2): a multicentre, open-label, phase 3, randomised, controlled trial 209
Osteonecrosis of the Jaw and Angiogenesis inhibitors: A Revival of a Rare but Serous Side Effect 208
hERG1 and HIF-2α Behave as Biomarkers of Positive Response to Bevacizumab in Metastatic Colorectal Cancer Patients 204
Evaluation of RAS mutational status through BEAMing assay to monitor disease progression of metastatic colorectal cancer: a case report 182
KRAS and NRAS mutation detection in circulating DNA from patients with metastatic colorectal cancer using BEAMing assay: Concordance with standard biopsy and clinical evaluation 181
Bevacizumab plus XELOX as first-line treatment of metastatic colorectal cancer: The OBELIX study 175
Endocrine toxicity in cancer patients treated with nivolumab or pembrolizumab: results of a large multicentre study. 170
Physical exercise and eating habits in cancer survivors 168
Circulating tumour cells in colorectal cancer 166
Effects of a home based exercise rehabilitation program for cancer survivors 159
Oxaliplatin-Based Chemotherapy in Advanced Neuroendocrine Tumors: Clinical Outcomes and Preliminary Correlation with Biological Factors 158
Metformin Use Is Associated With Longer Progression-Free Survival of Patients With Diabetes and Pancreatic Neuroendocrine Tumors Receiving Everolimus and/or Somatostatin Analogues 156
Temperament and character traits associated with health-related quality of life in cancer patients 141
A transcriptomic approach reveals selective ribosomal remodelling in the tumour versus the stromal compartment of metastatic colorectal cancer 135
Phase II trial of single-agent oral vinorelbine in elderly (> or =70 years) patients with advanced non-small-cell lung cancer and poor performance status 130
Regorafenib also can cause osteonecrosis of the jaw 130
Bevacizumab in non-small cell lung cancer 126
Randomized trial on adjuvant treatment with FOLFIRI followed by docetaxel and cisplatin versus 5-fluorouracil and folinic acid for radically resected gastric cancer. 124
Prognostic role of hERG1 Potassium Channels in Neuroendocrine Tumours of the Ileum and Pancreas 121
A multi-center study on the surgical management of metastatic disease to adrenal glands 120
Phase II study of 5-FU plus 6-S-leucovorin (6S-LV) in advanced colorectal cancer 119
ITACA-S (Intergroup Trial of Adjuvant Chemotherapy in Adenocarcinoma of the Stomach) Trial: comparison of a sequential treatment with irinotecan (cpt-11) + 5-fluorouracil (5-FU)/folinic acid (LV) followed by docetaxel and cisplatin versus a 5-FU/LV regimen as postoperative treatment for radically resected gastric cancer 119
Quality of life, compliance, safety and effectiveness in fit older metastatic colorectal patients with cancer treated in first-line with chemotherapy plus cetuximab: A restrospective analysis from the ObservEr study 118
Safety and efficacy of nivolumab for metastatic renal cell carcinoma: real-world results from an expanded access programme 86
Totale 4.635
Categoria #
all - tutte 13.941
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 13.941


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021274 0 0 0 0 0 0 39 40 53 83 32 27
2021/2022224 8 17 21 8 5 15 5 15 19 13 31 67
2022/2023608 57 131 33 27 38 110 76 36 68 5 15 12
2023/2024225 3 19 28 12 10 50 15 47 2 16 12 11
2024/20251.542 45 151 79 285 437 206 22 66 75 46 64 66
2025/2026872 175 197 88 87 181 75 69 0 0 0 0 0
Totale 4.635